Home / Market Update / Commodities / European Shares Decline Amid Trade Tensions and Tariff Threats

European Shares Decline Amid Trade Tensions and Tariff Threats

European stocks fell on Monday, driven by a sharp decline in the automobile sector, as investors reacted to the latest trade tariff threats from U.S. President Donald Trump.

Market Overview:

  • The pan-European STOXX 600 index was down 0.5%, at 544.74 points, as of 0830 GMT.
  • Other regional indexes also posted losses, with the UK’s FTSE 100 being the only exception, rising by 0.2%.

Trump’s Tariff Threats:

  • Over the weekend, Trump threatened to impose a 30% tariff on imports from the European Union and Mexico, effective August 1, following failed trade negotiations with major U.S. trading partners.
  • Trump’s threat sent ripples through the markets, especially after a long period of uncertain trade negotiations.
  • Michael Field, chief equity market strategist at Morningstar, noted that the market is reacting negatively, but there is still uncertainty about whether the tariffs will actually be implemented.

EU’s Response:

  • In response, the European Union extended its suspension of countermeasures on U.S. tariffs until early August, while continuing to push for a negotiated settlement.
  • Italy’s Foreign Minister Antonio Tajani emphasized that the EU had prepared a list of tariffs worth more than 21 billion euros ($24.5 billion) on U.S. goods, should talks break down.
  • Maros Sefcovic, the EU’s trade commissioner, emphasized that while the EU seeks a favorable trade deal with the U.S., it was also ready with countermeasures in case the negotiations failed.

Automobile Sector Hit Hard:

  • The European automobile sector took the hardest hit, falling by 1.5% in the wake of Trump’s tariff threats, with no special exemptions for cars.
  • Major carmakers saw significant declines:
    • Porsche dropped 2.4%.
    • BMW and Mercedes-Benz both fell 2%.
    • Volkswagen decreased by 1.9%.

Other Notable Stock Movements:

  • Lifco slumped 9.1% after missing second-quarter pre-tax profit expectations.
  • AstraZeneca rose 1.8% after its drug Baxdrostat met all goals in a late-stage study for patients with uncontrolled or treatment-resistant hypertension.

Outlook:

  • Morgan Stanley downgraded its 2025 MSCI Europe local currency earnings forecast to -1.0% from +1.3% due to the ongoing currency fluctuations and tariff uncertainties.

The market’s response highlights the continued uncertainty surrounding U.S.-EU trade relations and how it may affect European economies, particularly industries like automobile manufacturing.

Check Also

Oil Prices Edge Higher Amid Geopolitical Tensions and Supply Concerns

Oil prices rose modestly on Monday, extending Friday’s gains, as investors focused on the potential …